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Optimizing Biomaterials for iPSC-Derived Micro Heart Tissue Models 
By 
Huanzhu Jiang 
Master of Science in Biomedical Engineering 
Washington University in St. Louis, 2021 
Research Advisor: Professor Nathaniel Huebsch 
 
Hypertrophic Cardiomyopathy (HCM) is the most common inherited cardiovascular disease, 
where environmental forces and genetic mutations have been heavily linked to heart failure or 
sudden cardiac death in young people. However, how genetic mutations and environmental forces 
contribute to HCM phenotype are not well defined. To study the mechanisms and investigate the 
potential treatments of this disease, it is important to build a model to simulate mechanical loading 
and recreate micro-environment of cardiomyocytes. In vivo, surgical maneuvers like transaortic 
constriction allow the study of overload, but these approaches are low throughput and it is difficult 
to precisely control overload. In vitro models for mechanical overload have shown differences in 
results. In this study, I contributed to the development of an “overload enhanced iPSC-micro heart 
muscle (iPSC-μHM)” model, and optimized substrate preparation to improve quantitative analysis 
of tissue contractility and calcium handling. I also explored the possibility of using synthetic 
extracellular matrix on optimization of μHM model. Gelatin methacryloyl (GelMA), one of the 
most common photo-crosslinkable hydrogels, is applied to encapsulate cells. Results show 
successful reduction of autofluorescence during process of surface modification on substrates. 
Moreover, I showed the feasibility of cell encapsulated in GelMA, which can potentially reduce 
vi 
the number of cells required to form iPSC-μHM, and to simulate different stiffnesses of micro 
tissue by varying concentrations of GelMA and photo-initiators. 
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Chapter 1: Introduction  
Hypertrophic Cardiomyopathy (HCM) is the most common inherited cardiovascular disease 
happening to about 1 out of every 500 people, leading to cardiac arrhythmia, heart failure, and 
sudden cardiac death (Maron & Maron MS., 2013; Maron., 2018). Although at lower low 
incidence, HCM is the most important cause of sudden cardiac death in young athletes (Makarov., 
2020). Genetic studies have shown that mutations in the contractile sarcomere of cardiomyocytes 
are the most common cause to HCM by far, and the most frequent mutation that account for almost 
50% HCM patients is found in Myosin Binding Protein C (MYBPC3) (Carrier et al., 2015; Marian 
& Braunwald, 2017). While genetic defects of cardiac myocytes play the most critical role in 
leading to HCM, the penetrance of HCM phenotypes varies highly in different individuals with 
genetic mutations, and HCM cases without any sarcomere mutations were reported (Ingles et al., 
2017; Lorenzini et al., 2020). This indicates that environmental factors, such as mechanical 
overload caused by change of blood pressure and change of myocardial stiffness may also trigger 
changed in HCM phenotypes.  
Different in vivo and in vitro models have been developed to study HCM mechanisms, including 
potential synergy between mechanical loading and HCM mutations in order to provide future 
perspectives for HCM treatment (Guo & Huebsch, 2020; Mosqueira et al., 2019). In vivo models 
have showed their crucial role in studying mechanisms with their advantages, such as tractable 
genetic manipulation, but the difficulty in controlling mechanical overload, physiological 
differences between humans and animals, and time-consuming problems (Barefield et al., 2015; 
Milani-Nejad & Janssen, 2014) cannot be disregarded. Thus, in vitro systems for studying synergy 
between mechanical overload and HCM genetic mutations are needed.  
2 
Previous in vitro HCM models using single cell, 2D and 3D format showed conflicting results 
which urge the need for more accurate and standard model. Few of these studies investigated 
potential trigger – synergy between mechanical overload and genetic mutations to HCM 
phenotypes. (Birket et al., 2015; Cohn et al., 2019; Davis et al., 2016; Lan et al., 2013; Ma et al., 
2018; Ribeiro et al., 2017). 
A medium-throughput iPSC-micro heart muscle (iPSC-μHM) model was developed recently (Guo 
et al., 2020), which shows high potential to study synergetic effects of mechanical overload and 
genetic mutations on HCM phenotype by applying heterozygous MYBPC3 iPSC cell line. 
However, some limitations of this iPSC-μHM model were shown, such as increase in 
autofluorescence (Lee et al., 2013) during substrates preparation process, which affects the 
quantification of calcium transient (Figure 1). 
Glutaraldehyde (GA) can cause high autofluorescence defined as unwanted fluorescence sources. 
The unwanted visible emitters are generated during the process of reaction between GA and 
proteins or peptides. A study indicated that the existence of secondary amine in the molecule plays 
a crucial role in the formation of emissive species, and pH can also influence the generation of 
different emitters with different colors, for example, a yellow emitter can be formed at higher pH 
(Lee et al., 2013). Based on the possible mechanism, adjusting pH during reaction process or 
introducing a new chemical at the end of GA reaction by reacting with the fluorophores are 
potential ways to reduce or eliminate autofluorescence. However, pH change and a new added 
chemical may be toxic to cells, which are not practical in the application into optimization of the 
iPSC-μHM model. A simpler and effective way was proposed in this study.  
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Furthermore, engineered hydrogel is widely used in tissue engineering for tissue production and 
regeneration, which is the optimal material for 3D in vitro models due to its biocompatibility, 
biodegradability, and hydrophilicity (Graham., 1998). Gelatin methacryloyl (GelMA) is one of the 
most common photo-crosslinkable hydrogels used for tissue regeneration due to its optimal 
biological environment and fast photo-crosslinked process, and the visible light photo-crosslinking 
process makes GelMA possible for cell encapsulation with fewer biosafety problems, such as DNA 
damage and cancer (Noshadi et al., 2017). The mechanical properties and degradation rate of 
GelMA hydrogel can be modified by varying the methacrylation degree, photo-initiator 
concentration, temperature, and photo- polymerization time (Noshadi et al., 2017; Van et al., 
2000). Here, GelMA was tested using C2C12s by varying photo-initiator concentration, GelMA 
concentration, and photo-polymerization time to investigate a better polymerization condition 
which can be potentially applied into the iPSC-μHM model. 
4 
The goal of this study is divided into two parts based on the iPSC-μHM model – investigate an 
effective way to reduce autofluorescence during reaction between glutaraldehyde (GA) and 
APTES, and introduce GelMA to encapsulate cells to investigate the potential to lower cell 
densities and simulate varies tissue stiffnesses. This study shows a simple way to reduce 
autofluorescence, and possibly better condition in crosslinking GelMA for cells encapsulation that 
can potentially be uses in the iPSC-μHM model in the future. 
 
 
Figure 1. Autofluorescence caused by GA on the substrates surface.  
  
5 
Chapter 2: Materials and Methods 
 
Polydimethylsiloxane (PDMS) Substrate Preparation 
To simulate different mechanical overloads, Sylgard 184 and Sylgard 527 were mixed at different 
ratios to manipulate and control substrate stiffness (Palchesko et al., 2012). Sylgard 184 (Dow 
Corning; Midland, MI) elastomer was mixed in a ratio of 1:10 (base to curing agent), and Sylgard 
527 was mixed in a ratio of 1:1 (base to curing agent). The whole fabrication process followed a 
previous method (Guo et al., 2020). To study the surface modification situation, Sylgard 184 was 
only applied here in 24 well plates.  
 
“Dog-Bone-Shaped” Stencil Molds Fabrication 
The “dog-bone-shaped” stencil molds (Figure 2A) were fabricated and assembled following a 
previous protocol (Guo et al., 2020). PDMS (Sylgard 184, 2 MPa) was poured over predefined 
3D-printed molds (MicroFine Green; Protolabs, Inc., Maple Plain, MN) designed by SolidWorks 
(Dassault Systèmes SE, Vélizy-Villacoublay, France). The thickness of each knob of each “dog-
bone-shaped” stencil mold is 1 mm, and each mold has two 1 mm × 1 mm knobs, which are 
connected by a 1 mm × 200 μm shaft. The “dog-bone-shaped” stencil molds were cured at 60°C 
overnight. To avoid tissue attachment to stencils surface, stencils were soaked in 10% F68 Pluronic 
for at least 45 min at room temperature followed by 3 washes using dPBS. Then stencils were 
soaked into methanol and attached onto substrates. The attachment between stencils and substrates 
was achieved through incubation for 2 hours at 60°C to evaporate methanol. The assemble devices 
were sterilized with 70% sterile ethanol for at least 3 hours. Upon sterilization, all the ethanol was 
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aspirated, and 5 μg/mL fibronectin was seeded inside stencils (3 μL/ “dog-bone-shaped” stencil) 
for 3 hours followed by 3 washes using dPBS before seeding cells.  
 
Substrates Surface Modification 
To achieve strong mechanical bonding between tissue and substrates, surface modification was 
applied to get covalently ECM protein (bovine plasma fibronectin, FN; Sigma; Millipore Sigma; 
St. Louis, MO)–grafted substrates following the previous protocol (Figure 2B) (Guo et al., 2020). 
Cured substrates were firstly treated with plasma oxidization (Harrick plasma, Ithaca, NY; 
pressure/flow rate: 580−680 mTorr) for 90 s at high power (30 W). Upon plasma treatment, amino 
silane chemistry was conducted by adding (3-aminopropyl) triethoxysilane silane (APTES; 5% 
v/v in methanol, Sigma) onto the surfaces of each substrates immediately. The reaction was 
conducted at 60°C for 1 hour to graft amine groups to substrate surfaces. After 1 hour of APTES 
reaction, substrate surfaces were washed with methanol for three times and 5 min for each time to 
remove unreacted APTES. To investigate the way to reduce strong autofluorescence caused by 
Glutaraldehyde (GA), substrates were incubated in Dulbecco’s phosphate buffered saline (dPBS) 
for 24 hours at room temperature after methanol washes. GA (Thermo Fisher Scientific; Waltham, 
MA, 2.5% v/v in dPBS) reaction was performed on the shaker for 2 hours at room temperature to 
act as an amine-reactive crosslinker,  followed by 3 washes using dPBS (with or without 24 hours 
of dPBS incubation) before FN reaction. FN (15 μg/mL in dPBS) reaction was applied on the 
shaker for at least 30 min at room temperature. After FN grafting, substrate surfaces were washed 
for 3 times with dPBS (5 min each time) and then were washed with deionized water for another 
3 times (5 min each time). Then ethanolamine hydrochloride (EtOH-Amine; Thermo Fisher 
Scientific, 2.5% w/v in dPBS) was applied to the substrate surfaces to quench unreacted GA 
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followed by 3 washes using dPBS. Fluorescent beads (1.06 μm diameter, Polysciences, Inc., 
Warrington, PA) were applied at the top of PDMS substrates through spinning coating to estimate 
the contraction of iPSC-μHM by tracking their displacements. 
 
Figure 2. iPSC-μHM device fabrication and surface characterization (Guo et al., 2020). (A) 
Schematic of “dog-bone-shaped” stencil assembly to substrate and tissue formation. Cells are 
seeded inside “dog-bone-shaped” stencils, and compact to form tissues; Formed tissues collapse 
and are detached from knob regions over time. (B) Schematic of substrate surface modification. 
APTES is applied and leaves amines on the surface after plasma oxidation. Reactive aldehydes are 
grafted onto amines after GA reaction. 
 
Fibronectin Bioactivity Characterization 
To make sure the bioactivity of FN did not get changed with the 24 hours of dPBS incubation, a 
previous antibody-based assay (García et al., 1999) was performed. Fibronectin antibody clone 
hFN7.1 (Developmental Studies Hybridoma Bank, Iowa City, IA) was applied to determine and 
quantify the bioavailability of integrin-binding epitopes in the substrate-adsorbed FN. Pure 
Sylgard 184 were poured into 24 well plates and got fully crosslinked, followed by plasma 
oxidation and APTES reaction. After either GA added immediately or 24 hours later after APTES 
reaction, different concentrations of human FN (Sigma, 0, 1.25, 5 and 20 g/mL in dPBS) were 
grafted to the substrate surfaces followed by 3 washes using dPBS and 3 washes using deionized 
water. Goat serum (Invitrogen, Carlsbad, CA) and bovine serum albumin (BSA, Sigma) were 
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reconstituted into 3% respectively with 0.1% Triton-X-100 (Thermo Fisher Scientific, diluted in 
dPBS) to be used as the blocking buffer. The blocking buffer was added to the substrate surfaces 
and the reaction was performed at room temperature for 45 min. After blocking reaction, hFN7.1 
(2 μg/mL in blocking buffer) binding reaction was conducted for 1 hour at room temperature 
following the primary antibody incubation assay. 3 thorough washes using 0.1% Triton-X-100 
were followed. Li-COR IRDye 800cw secondary antibody (LI-COR Biosciences, Lincoln, NE, 
100 ng/mL in Milli-Q water) was applied to react for 1 hour at room temperature, followed by 0.1% 
Triton-X-100 wash buffer washes for 3 times. Then the substrate surfaces were scanned with a Li-
COR Odyssey CLx scanner (LI-COR Biosciences), and hFN7.1 fluorescence intensity was 
measured with Image Studio Lite Version 5.2.5. (Guo et al., 2020). 
 
iPSC-μHM Calcium Transient 
iPSC cell culture, cardiomyocyte differentiation, iPSC-μHM formation on substrates, and the 
analysis of iPSC-μHM contractility and calcium transient were conducted to study cardiac 
physiology following the protocol (Guo et al., 2020). The genetically encoded calcium indicator, 
GCaMP6f were applied to visualize calcium dynamics on substrates with different stiffnesses 
(afterload) and study stiffness effects on calcium handling (Figure 3) ( Guo et al., 2020; Huebsch 
et al., 2015). At least 3 regions without fluorescent beads were selected for each video imaged at 
100 frames per second to analyze calcium handling to prevent the effects of fluorescent beads due 
to the condition that fluorescent beads and the calcium signal are both green fluorescence. A 
custom MATLAB code (Ma et al., 2018) was used to separate and analyze individual waveforms 
to obtain calcium transient values. Fridericia’s formula (Fridericia, 2003) was used to reduce the 
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effects of different spontaneous beat rate on calcium transient. GCaMP intensity (amplitude) over 
time can be integrated to get calcium flux. 
 
Figure 3. GCaMP6 signal traces (Guo et al., 2020). (A) Representative traces of iPSC-μHM on the 
5 kPa substrate on Day 16. (B) Representative calcium transient with upstroke and decay times 
noted. 
 
Synthesis and Preparation of GelMA 
GelMA was prepared and synthesized on the basis of previous protocols (Figure 4A) (Kerscher et 
al., 2017; Nichol et al., 2010; Van et al., 2000; Zhu et al., 2019). Gelatin (Type B, bovine skin, 
Sigma) was mixed into dPBS in a ratio of 5% (w/v) on the stir play at 60°C to ensure gelatin 
powder got fully dissolved. Methacrylic anhydride (MA, Sigma, 15% w/v in gelatin solution) was 
added into fully dissolved gelatin solution constantly at the rate of 0.5 mL/min. The MA reaction 
was performed at 60°C for 2 hours on the stir play. Then the reaction was stopped with 60°C dPBS. 
The volume of dPBS for stopping the reaction is 5 times of original fully dissolved gelatin solution. 
The mixture was put into 10k MWCO dialysis tubes (Thermo Fisher Scientific) and dialyzed at 
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60°C for 7 days using deionized water. The GelMA solution was lyophilized for 5-7 days and 
stored in the -80°C freezer for use. 
 
Preparation and crosslinking of GelMA Hydrogel 
GelMA hydrogel is crosslinked through photoinitiated method by combining Eosin Y 
photoinitiator with triethanolamine (TEA) and N-vinypyyrolidone (NVP). Free radicals are 
generated from the photoinitiator which initiates the chain polymerization of the methacryloyl 
groups (Figure 4B) (Noshadi et al., 2017). Visible light UV was used here, which is a more 
suitable light source to crosslink GelMA, because studies have shown that UV light might 
potentially cause DNA damages in the cells (Kerscher et al., 2017). 
 
Lyophilized GelMA was mixed and dissolved into dPBS at a concentration of 150 mg/mL (15%). 
To investigate a proper concentration of different components in the crosslinker for GelMA 
crosslinking, different 10X crosslinkers were prepared containing different concentrations of 
triethanolamine (TEA, Sigma, 1-15% v/v), Eosin Y (Sigma, 0.1-2mM), 369 mM 1-vinyl-2-
pyrrolidinone (NVP, Sigma). Eosin Y was first dissolved in Dimethyl sulfoxide (DMSO, Sigma) 
to reach 100mM. The precursor solution was prepared by combining 15% lyophilized GelMA 
solution, 10X crosslinker and then dissolving them in dPBS to reach 7.5% or 10% GelMA 
precursor solution. Then the precursor solution was crosslinked by being exposed to LED light 
(Otdair RGB LED Floodlight) for 2.5-20 min to get GelMA hydrogel. 
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Figure 4. Synthesis and crosslinking of GelMA hydrogel ( Zhu et al., 2019; Noshadi et al., 2017). 
(A) Methacryloyl groups are grafted onto the gelatin backbone after the reaction of gelatin and 
methacrylic anhydride. (B) Schematic of photo-crosslinking reaction of GelMA to form hydrogel 
network. Photoinitiator (Eosin Y) and Organic initiators (NVP, triethanolamine) produce free 
radicals to initiate chain polymerization to crosslink methacryloyl groups from one polymer chain 
to another polymer chain.  
 
Mechanical Compression Testing of GelMA 
7.5% or 10% GelMA precursor solutions combined with different concentrations of Eosin Y (10, 
20 and 50 μM) were prepared following the protocol as described before. 90 μL GelMA precursor 
solution was put onto an acrylic plate, then covered with another acrylic plate, and two plates were 
separated using 1mm thick glass coverslips to make sure the surface of GelMA hydrogel is flat 
and the thickness of each hydrogel is 1mm. GelMA precursor solution was exposed to LED light 
for 10 or 20 min. Stiffness of hydrogel was measured using ElectroForce 3200 (TA Instruments) 





Compaction study of C2C12s Encapsulated in GelMA 
7.5% or 10% GelMA precursor solutions combined with different concentrations of Eosin Y (10, 
20 and 50 μM) were prepared following the protocol as described before. Cells were first mixed 
with GelMA precursor solution, then the mixture was added in 96 well plates (2 μL/droplet) or 
seeded the mixture in “dog-bone-shaped” stencil (3 μL/ “dog-bone-shaped” stencil) separately, 
and then exposed them to LED light for 2.5 or 5 min to crosslink. The areas of GelMA were 
measured on Day 0, Day 6, Day 10, and Day 15.  
 
Micro Tissue Formation 
C2C12 fibroblasts were singularized using 0.05% Trypin and resuspended into Dulbecco’s 
Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) or GelMA precursor 
solutions before seeded to “dog-bone-shaped” stencils. Upon pure cells were seeded into stencils, 
incubation at 37°C for 2 hours should be performed before adding DMEM with 10% FBS into 
each well. DMEM with 10% FBS was added immediately when GelMA was crosslinked. Cells 
will self-assemble with GelMA to form 3D tissue. The cells densities of 2.5 × 107, 5 × 107, 8 × 107 





Chapter 3: Results of Optimization of Surface modification and GelMA Crosslinking 
 
 
Reduction of Substrates Autofluorescence 
Since pH adjustment and addition of new chemicals are not suitable for the optimization, we 
proposed a way where we added a period of incubation in dPBS after APTES grafting before GA 
reaction, which was proven an effective way to reduce autofluorescence. GA reacting 24 hours 
after APTES grafting resulted in significant lower autofluorescence (Guo et al., under review). 
The prolonged incubation in dPBS reduced the activity of APTES grafted on the substrates surface 
and washed out unreacted APTES, thus reduced autofluorescence caused from reaction of APTES 
and GA, which can also reduce toxicity from the unreacted silane.   
 
 
Changes of Fibronectin Bioactivity 
 
The characterization of FN binding affinity between different surfaces using FN antibody binding 
assays indicated that the dPBS incubation did not alter FN bioactivity, when lowering the 
substrates autofluorescence (Guo et al., under review). When hFN concentration increased, the 
hFN 7.1 fluorescent intensity increased, no significant difference was found between two surfaces. 
 
iPSC-μHM Calcium handling  
The effects of afterload on iPSC-μHM Calcium handling were investigated and data were shown 
(Figure 5) (Guo et al., 2020). Higher afterload causing higher calcium and net flux was observed 
(Figure 5A, B). However, lowest upstroke duration (Figure 5C) and calcium decay value (Figure 
5D) were captured on iPSC-μHM on 15 kPa substrates. Calcium decay times on Day 16 were 
significantly larger than times on Day 6. No significant differences were indicated on calcium 
amplitude on substrates with different stiffnesses on Day 9. But stiffer substrates tended to lead to 
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increase of calcium amplitude. On Day 9, iPSC-μHM on 30 kPa substrates has significantly higher 
integrated calcium flux than iPSC-μHM on 5 and 15 kPa (Figure 5B). A significant longer 
upstroke time (p=0.008, Figure 5C) calcium decay times (p=0.0005, Figure 5D) of iPSC-μHM 
on 30 kPa substrates than other two groups. On Day 16, stiffer substrates led to significantly higher 
calcium amplitude and calcium flux (Figure 5A, B).  
 
Figure 5. iPSC-μHM calcium transient on substrates with different stiffnesses on Day 9 and 16 
(Guo et al., 2020). (A) Stiffer substrates led to higher calcium amplitude (p=0.035) on Day 9. On 
Day 16, no significant differences were observed in calcium amplitude between iPSC-μHM on 5 
and 15 kPa substrates (p=0.560), while 30 kPa substrates led to significantly higher value 
compared to other two groups respectively (p=0.0002, p=0.0012). (B) On Day 9, no significant 
differences of integrated calcium flux between 5 and 15 kPa conditions were indicated (P=0.316). 
The 30 kPa condition had a significant higher flux than 5 kPa (p=0.003) and 15 kPa (p=0.043) 
conditions. On Day 16, 5 kPa and 15 kPa conditions showed no significant differences between 
them (p=0.615), but they both showed significantly lower flux than the 30 kPa condition 
(p<0.0001). (C) Upstroke duration of the 15 kPa condition showing the lowest value was 
significantly lower than the 30 kPa condition on both Day 9 (p=0.008) and 16 (p=0.002). (D) The 
decay time indicated by calcium τ75 showed that the 30 kPa condition was significantly higher 
than the 15 kPa condition (p=0.0005) on Day 9. On Day 16, decay time of both 5 and 15 kPa 
conditions was significantly lower than the 30 kPa condition (p<0.0001). The 5 kPa condition had 
significantly longer decay time than the 15 kPa condition on Day 16 (p=0.009). ****, ***, **, and 




Photo-initiator Concentrations for GelMA Crosslinking 
 
Eosin Y at a concentration higher than 100 μM and TEA at a concentration higher than 1.5% v/v 
are toxic to human mesenchymal stem cells (hMSCs) (Bahney et al., 2011). Based on this, I tested 
5-100 μM Eosin Y and 0.05-1.5% TEA, different concentrations of GelMA (1.5%, 5%, 7.5% and 
10%) and different photoinitiation times using total volume of 3 μL precursor solution for each 
sample (Table 1). We used pipette tips to gently poke the surface of each sample after exposed to 
LED light for 2.5 min to observe if GelMA was crosslinked. By trying different concentrations of 
Eosin Y, TEA and GelMA, 10, 20 and 50 μM Eosin Y, 1.5% v/v TEA, and 7.5% and 10% GelMA 
in the final precursor solution were applied in the further study. 
 
Table 1. Design and results of different input parameters for GelMA crosslinking testing.  
 
 
However, GelMA with higher volume could not crosslink with 2 min of photo-polymerization 
time. The time for GelMA to crosslink completely is related to thickness of GelMA, but the this 





Mechanical Properties of GelMA 
 
Based on previous study, higher volume of GelMA needs longer time to crosslink. To make sure 
GelMA hydrogels used for mechanical testing can crosslink, we used the same observation method 
here – tips were applied to gently poke the surface of each sample after the certain time of exposure 
to light. At least 8.5 min light exposure was needed for 90 μL 7.5% GelMA to crosslink. 
 
Higher concentration of Eosin Y and higher concentration of GelMA led to significantly higher 
stiffness (Figure 6A). However, 10% GelMA did not generally cause a significant increase of 
stiffness compared to 7.5% GelMA with the same crosslinking conditions. There are no significant 
differences among 5 conditions, which were: 10% GelMA_10 μM Eosin Y, 10% GelMA_20 μM 
Eosin Y, 7.5% GelMA_20 μM Eosin Y, 7.5% GelMA_50 μM Eosin Y and 10% GelMA_50 μM 
Eosin Y. 7.5% and 10% GelMA were tested with the same concentration of Eosin Y under the 
different crosslinking times, and the results showed that there were no significant differences 
between 10 min and 20 min (p=0.4988, Figure 6B). One possibility is that GelMA can fully 
crosslink with 10 min light exposure, and the additional light exposure did not alter much of 
mechanical properties of GelMA. The results from different batches of GelMA showed that there 
is a good consistency between different batches in terms of relatively stable mechanical properties 
(Figure 6C).   
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Figure 6. The results of mechanical properties of GelMA. (A) GelMA stiffness under conditions 
of 10% GelMA_10 μM Eosin Y, 10% GelMA_20 μM Eosin Y, 7.5% GelMA_20 μM Eosin Y, 
7.5% GelMA_50 μM Eosin Y and 10% GelMA_50 μM Eosin Y. The stiffness of 7.5% GelMA 
_10 μM Eosin Y was significantly larger compared to 7.5% GelMA_50 μM Eosin Y (P=0.0409) 
and 10% GelMA_50 μM Eosin Y (p=0.0213). (B) No significant difference was indicated in the 
stiffness of GelMA (50 μM Eosin Y) with different light exposure times (p=0.4988). (C) The 
stiffness of GelMA from Batch 6 with 20 μM and 50 μM Eosin Y showed significant difference 
(p=0.0492). No significant differences were shown in other batches. * indicates p < 0.05. 
 
 
Compaction of GelMA 
 
The cells densities of 2.5 × 107, 5 × 107, 8 × 107 cells/mL were tested here. Different densities of 
cells were encapsulated in 10% GelMA and plated into 96 well plates, and each sample was 2 μL 
(Figure 7A-B). GelMA compaction was observed, and GelMA with higher cell density tend to 
cause higher compaction. After day 6, the compaction slowed down and stabilized in the 
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conditions of 10% GelMA_5e7/mL cells and 10% GelMA_8e7/mL cells (Figure 8A). While in 
the condition of 10% GelMA_2.5e7/mL cells, gel areas became bigger on Day 10 than before. One 
possibility is that enlarged gel area after Day 10 was caused by incomplete cell encapsulation, and 
cells grew outside the gel which the stretched gel will help prevent further compaction. (Figure 
7C, Figure 8A). When media was added into each well, some cells were washed out of GelMA, 
and spread to plates surface, then started to grow. At first, during Day 0 and Day 6, cells inside 
GelMA started to form tissue and pulled GelMA from inside. However, cells outside GelMA grew 
and prolificated as well, and pulled GelMA from outside, causing some areas of GelMA become 
bigger. To prevent the issue, in “dog-bone-shaped” stencil systems, stencils were optimized by 
incubating in 10% F68 Pluronic prior to the assembly, which can help avoid cell attachment, and 
therefore, gel compaction process can be evaluated more accurately. I observed that higher Eosin 
Y concentration caused less compaction compared to lower Eosin Y concentration (Figure 8B-
D). 50 μM Eosin Y caused higher GelMA stiffness than 10 μM Eosin Y. Stiffer GelMA caused by 
higher Eosin Y concentration made it harder for cells to deform. That is why compaction process 
was relatively slow in the 50 μM Eosin Y condition (Figure 7B-C). I found that when cell density 
was lower than 5 × 107 cells/mL, there is not enough cells to compact from both knob regions in 
“dog-bone-shaped” stencils, and cells tended to form small “ball-shaped” tissue in knob regions 
(Figure 9A). However, cells of high densities tended to detach from bottom surface and started to 
collapse in a short time (Figure 9B). Therefore, I incorporated GelMA hydrogel to improve tissue 
formation and compaction. I found that even with low density of cells (2.5e7 cells/mL), tissue can 
form and compact in GelMA hydrogel within “dog-bone-shaped” stencil (Figure 9C). Moreover, 
cells encapsulated in GelMA can prevent tissue from detachment from the substrates.  
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Figure 7. Representative images of cells encapsulation. (A) Cells with the density of 2.5e7/mL 
were encapsulated in 10% GelMA (20 μM Eosin Y) on Day 0. (B) Cells with the density of 5e7/mL 
were encapsulated in 10% GelMA (20 μM Eosin Y) on Day 0. (C) Cells with the density of 
2.5e7/mL were encapsulated in 10% GelMA (20 μM Eosin Y) on Day 10.  
 
 
Figure 8. Quantification of tissue occupied area (normalized to Day 0). (A) GelMA compaction 
showed no significant difference between 10% GelMA encapsulating different densities of cells 
on the same day. The area of 10% GelMA_8e7/mL cells condition on Day 6 was significantly 
larger than Day 0 (p=0.0410). (B) The area Cells encapsulated in GelMA (10 μM Eosin Y) 
significantly decreased on Day 6 compared to Day 0 (p=0.0319). On Day 15, the areas between 
conditions of 20 and 50 μM Eosin Y indicated significant difference (p=0.0492). (C) 10% GelMA 
compaction indicated the similar trends as 7.5% GelMA encapsulating cells with the same density. 
(D) The conditions of cells only and 7.5% GelMA_10 μM Eosin Y showed significant difference 
between Day 0 and Day 6 respectively (p=0.0143, P=0.0349). On Day 10 and Day 15, the area of 
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cells only was significantly smaller than those of 7.5% GelMA_10 μM Eosin Y and 10% 




Figure 9. Representative images of tissue formation in “dog-bone-shaped” stencils on Day 6. (A) 
Cells with the density of 2.5e7/mL compacted and formed “ball-shaped”. (B) Cells with the density 
of 8e7/mL detached from the knob regions and started to collapse. (C) Cells with the density of 






Chapter 4: Discussion and Conclusion 
 
In this study, we optimized the previous developed iPSC-μHM models by modifying surface 
chemistry during substrates fabrication, and investigated various GelMA conditions for cell 
encapsulation. In the experiments of surface modifications for substrate fabrication, the results 
showed that the prolonged dPBS incubation reduced the autofluorescence intensity significantly, 
and FN bioactivity did not show significant differences, compared to previous substrates without 
dPBS incubation. Kwahun Lee et al. have found autofluorescence intensity can be influenced by 
pH (Lee et al., 2013). An environment with high pH can promote the formation of red emitters, 
but higher pH would suppress the generation of red emitters and accelerate the generation of 
yellow emitters. Lower pH had the potential to reduce autofluorescence intensity, however, would 
induce other emitters, such as green and blue emitters. They also added hydroquinone to eliminate 
autofluorescence, and found hydroquinone incubation can eliminate autofluorescence at a very 
high pH. In the meantime, the reduction of autofluorescence caused by addition of hydroquinone 
was strongly related to pH. For example, pH at 7 would excite other fluorescence peaks 
(Carmichael & Mander, 1967). Overall, adjusting pH or addition of other chemicals are not ideal 
ways to reduce autofluorescence in our system.  
 
In addition, we investigated the mechanical properties of GelMA for its potential application in 
our iPSC-μHM model. In previous study, it has been proven that mechanical properties are related 
to concentrations of photo-initiator. Interestingly, the results in our study showed that there is no 
significant difference of stiffness between 7.5% GelMA and 10% GelMA with concentrations of 
Eosin Y from 10-20 μM. One possibility is that the degree of substitution of GelMA is much lower 
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than we expected, causing less chemical crosslinking of polymer chains (Van et al., 2000). With 
higher degree of substitution, the mechanical properties would vary significantly by reducing or 
increasing concentrations of Eosin Y as well as concentrations of GelMA. Based on the protocol 
that we used and modified, the addition of MA at a constant and slow rate of 0.5 mL/min during 
synthesis process and frequent water changing during dialysis process helped make sure the batch 
to batch consistency in terms of mechanical properties, which is important in GelMA application. 
However, it also led to the lower degree of substitution than expected, which is consistent with the 
observations by Kerscher et al. (Kerscher et al., 2017) following the similar protocol. Zhu et al. 
proposed a highly controllability one-pot strategy to ensure the batch to batch reproducibly and 
controllability when producing GelMA (Zhu et al., 2019). In their study, they successfully 
exhibited highly consistent GelMA in terms of highly consistent compositional, structural, and 
functional properties between different batches with expected degree of substitution via the one-
pot method. In the compaction study, we compared conditions of cells only and cells encapsulated 
in GelMA in “dog-bone-shaped” stencils. When tissue in the cells only condition started to 
collapse, the cells encapsulated in GelMA still continued to compact without any detachment. 
When GelMA was stiffer, it became harder for cells to compact, which could simulate the stiff 
tissue condition. It could be a potential way to simulate hardening of heart muscle due to HCM by 
applying GelMA with different mechanical properties. Based on this, through GelMA 
encapsulating cells, not only could we simulate tissue stiffness, but also slow down the process of 
tissue detachment and collapse in “dog-bone-shaped” stencils.  
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Overall, the study demonstrated an effective way to optimize the iPSC-μHM model by optimizing 
surface chemistry and explored the potential application of GelMA to optimize the tissue formation 




Chapter 5: Limitations and Future Work 
 
 
From this study, we have demonstrated an effective way to reduce autofluorescence and optimized 
our previously developed substrate fabrication process, and investigated the possibility of 
application of GelMA in our iPSC-μHM model. However, there are still some problems to be 
solved and some limitations to be overcome to optimize our model.  
 
Although the prolonged period of dPBS incubation has showed the successful reduction of 
autofluorescence during surface modification process of substrates, there are still some 
autofluorescence shown on the substrates surface, affecting the observation and imaging of micro 
heart muscle tissue, and capture and analysis of calcium transient. Moreover, 24 hours of dPBS 
incubation would make the process of substrate fabrication more time-consuming, on the basis of 
long preparation time, such as PDMS curing process and sterilization process. dPBS incubation is 
a simple and effective way so far, but a better way still needs to be created. We’ve known that the 
existence of secondary amine is the key to generate emissive species and cause autofluorescence, 
a possible way to reduce the autofluorescence is to use alternative silanes besides APTES to 
minimize secondary amine groups.  
 
C2C12 encapsulation in GelMA has shown a promising application to be used in our iPSC-μHM 
model. However, the degree of substitution of methacryloyl group remains low following the 
protocol that we are using, and the relationship between mechanical properties and thickness of 
GelMA or total volume of GelMA on the basis of different crosslinking time is still not clear. The 
crosslinking condition and mechanical properties of GelMA that we synthesized are limited by 
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GelMA concentrations, for example, low concentration of GelMA makes it hard to crosslink with 
low methacryloyl substitution. Modification on increasing the methacryloyl substitution degree 
may be needed to increase mechanical tunability of GelMA, and more experiments may need to 
be conducted to investigate the relationship of crosslinking time and thickness of GelMA and its 
effects on mechanical properties of GelMA to get more accurate mechanical properties of GelMA 
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